Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma

Abstract
Background: Recent clinical studies showed that lipoprotein-associated phospholipase A2 (Lp-PLA2) is a predictor for incident atherosclerotic disease. We have previously shown that among the LDL subfractions, Lp-PLA2 activity is preferentially associated with the atherogenic small, dense (sdLDL) particles in vitro. We investigated whether Lp-PLA2 could be a marker of sdLDL in human plasma.

This publication has 31 references indexed in Scilit: